Skip to Content

Treatment of Autoimmune Patients with CD19-CAR T Cells Results in Long-Term Drug-Free Remission or No Progression

Fabian Müller from the University Clinic of Erlangen presented updated data on the treatment of autoimmune patients with CD19-CAR T-cell therapy at ASH 2024. Data from 35 patients demonstrated a 100% remission rate at six months with a strong safety profile and deep B-cell depletion. Long-term follow-ups revealed long-term drug-free remission or no progression, with disease recurrence in only one patient

Fabian Müller

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top